Page results
-
The Haemophagocytic Lymphohistiocytosis (HLH) Service was established at UCLH to offer high-quality care for people suspected of having HLH.
-
UCLH needs to reduce the amount we consume per patient, re-use and re-manufacture what we can and ensure that what we do use has minimal environmental impact. We also need to ensure our suppliers match our environmental ambitions. This page explores our progress so far.
-
Coping with nausea patient information page.
-
Professor Hough is a consultant heamatologist at UCLH. She has specialist expertise in the management of acute lymphoblastic leukaemia in teenagers and young adults, and the use of umbilical cord blood as an alternative source of haemopoietic stem cells.
-
Dr Sen is a triple accredited consultant physician in stroke, geriatric and general internal medicine
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
This information is intended for patients who are receiving GnRH-a injections as part of their treatment at UCLH.
-
There is industrial action by resident doctors (formerly known as junior doctors) from 7am on Friday 25 July until 7am on Wednesday 30 July.
-
Volunteers are a highly valued part of the team at UCLH. Volunteering is a great way of giving back, doing something different and get some experience. Roles tend to be for a minimum of half a day a week for 6 months. For most of our roles you don’t necessarily need have to have prior experience as the key things we are looking for are great people skills and an ability to give us a regular commitment.
-
The flow cytometry laboratory provides a Haematological Malignancy diagnostic service which includes chronic and acute leukaemias and lymphomas.
File results
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment